1. Home
  2. Clinical Topics
  3. FDA approves new product to treat hereditary angioedema
Clinical TopicsDrugs and DevicesImmune/Lymphatic SystemNewsWeb Exclusives

FDA approves new product to treat hereditary angioedema

Share
By:

On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.
Read more.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts